Subscribe
Subscribe today to receive CGD’s latest newsletters and topic updates.
All Commentary
Filters:
Topics
Facet Toggle
Content Type
Facet Toggle
Blog Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
April 08, 2024
When Gavi, the Vaccine Alliance, was founded in 2001, it logically targeted its support to the poorest countries—with GNI per capita under a pre-defined eligibility threshold—that also had the highest shares of the world’s undervaccinated children. Fast-forward almost 25 years, and the situation has...
Blog Post
February 22, 2024
The process of discovering, producing, buying, and consuming antibiotics is riddled with market and government failures. To solve antibiotic resistance, it’s not enough to solve just some of these. If we fix the market failures that reduce the number of new antibiotics that are discovered, but not t...
Blog Post
June 13, 2023
This Thursday, the Center for Global Development is hosting a half-day event—Get the Lead Out—to shine a much-needed spotlight on the far-reaching social and economic consequences of lead poisoning. Lead is an insidious toxin. In most cases, it has no overt, easily detectable symptoms when ingested—...
Blog Post
May 24, 2023
The Working Group has been built on existing proposals and initiatives which people from across the AMR space have kindly taken the time to share with us during the last 18 months. Indeed, more than 60 percent of people that we interviewed as part of our Landscape Review highlighted the need for a b...
Blog Post
February 06, 2023
Today, we publicly launch an independent assessment which offers an overview of the global lead poisoning crisis; takes stock of current initiatives within G7 partners and international organisations to reduce lead poisoning globally; and identifies promising opportunities to make a difference. Here...
Blog Post
December 08, 2022
The world desperately needs new antibiotics—and finally, the G7 is ready match commitments with action. We already found that the US would pay $17.9 billion over 30 years but save 383,000 American lives and harvest $495 billion in value. What would be the benefits to other members of the G7, and who...
Blog Post
December 02, 2022
An important debate is taking place in Europe right now on how to fund new antimicrobials. For months it has been speculated that the European Union may move towards implementing transferable exclusivity vouchers (TEVs). In response, 14 Member States wrote to the European Commission outlining why th...